IILS: Intelligent imaging layout system for automatic imaging report standardization and intra-interdisciplinary clinical workflow optimization
Yang Wang(Shanghai Jiao Tong University), Bing Zhang(China Pharmaceutical University), Cailiang Gao(Chongqing University), Guanmin Zheng(University of Michigan), Hongming Yu(Nanjing University of Chinese Medicine), Lu Cao(Chinese People's Liberation Army), Kefeng Zhou(Gaochun People's Hospital), Hu Zhu(Beijing Normal University), Yingwei Zhang(Changchun Institute of Applied Chemistry), Chaowei Zhao(Jiangxi Academy of Sciences), Hui Li(China-Japan Friendship Hospital), Danyan Li(Capital Medical University), Wen Yang(Wuhan University), Guangming Lu(Nanjing General Hospital of Nanjing Military Command), Xiaoyan Xin(Cangzhou Central Hospital), Libo Tan(University of Alabama), Mingran Shao(Nanjing Drum Tower Hospital), Fangrong Yan(China Pharmaceutical University), Fei Zhou(Shandong University), Chen Wang(Chinese Academy of Medical Sciences & Peking Union Medical College), Qing Zhao(Nanjing Drum Tower Hospital), Jing Ye(Northern Jiangsu People's Hospital), Fei Chen(Wuhan National Laboratory for Optoelectronics), Han Wang(Zhejiang University), Yong Chen(Ningxia Medical University), Lihua Yuan(Nanjing Drum Tower Hospital), Rui Deng(Dalian Medical University), Aijing Li(Ningbo No. 2 Hospital), Yue Zhu(China Pharmaceutical University), Xin Dou(Nanjing Drum Tower Hospital), Zhuping Zhou(Nanjing Drum Tower Hospital), Nan Zhou(Nanjing Drum Tower Hospital), Qi Zhao, Xin Zhang(Hefei University), Xiaofan Lu(Centre National de la Recherche Scientifique)
Cited by 42
Related Papers
A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
|New England Journal of Medicine|2020|5.5k
RETRACTED: 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study
|The Lancet|2021|4.3k
Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial
|The Lancet|2020|3.7k